221 related articles for article (PubMed ID: 17467249)
1. Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):481-9. PubMed ID: 17467249
[TBL] [Abstract][Full Text] [Related]
2. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach.
Barbera L; Zhang-Salomons J; Huang J; Tyldesley S; Mackillop W
Med Care; 2003 Sep; 41(9):1074-85. PubMed ID: 12972847
[TBL] [Abstract][Full Text] [Related]
3. Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):801-9. PubMed ID: 20797840
[TBL] [Abstract][Full Text] [Related]
4. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.
Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK
Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937
[TBL] [Abstract][Full Text] [Related]
5. Management and outcome of glottic cancer: a population-based comparison between Ontario, Canada and the SEER areas of the United States. Surveillance, Epidemiology and End Results.
Groome PA; Mackillop WJ; Rothwell DM; O'Sullivan B; Irish JC; Hall SF; Warde PR; Holowaty EJ
J Otolaryngol; 2000 Apr; 29(2):67-77. PubMed ID: 10819103
[TBL] [Abstract][Full Text] [Related]
6. Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia.
Tyldesley S; Delaney G; Foroudi F; Barbera L; Kerba M; Mackillop W
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1507-15. PubMed ID: 20605338
[TBL] [Abstract][Full Text] [Related]
7. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
8. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
Shack L; Lu S; Weeks LA; Craighead P; Kerba M
Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795
[TBL] [Abstract][Full Text] [Related]
9. Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines.
Delaney G; Shafiq J; Chappell G; Barton M
Cancer; 2008 May; 112(9):1912-22. PubMed ID: 18318431
[TBL] [Abstract][Full Text] [Related]
10. Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
McCammon R; Finlayson C; Schwer A; Rabinovitch R
Cancer; 2008 Aug; 113(4):683-9. PubMed ID: 18543316
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario.
Whelan T; Marcellus D; Clark R; Levine M
CMAJ; 1993 Nov; 149(9):1273-7. PubMed ID: 8221482
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer.
Zablotska LB; Chak A; Das A; Neugut AI
Am J Epidemiol; 2005 Feb; 161(4):330-7. PubMed ID: 15692076
[TBL] [Abstract][Full Text] [Related]
13. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
Kong W; Jarvis C; Mackillop WJ
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
[TBL] [Abstract][Full Text] [Related]
14. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
[TBL] [Abstract][Full Text] [Related]
15. Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: analysis of the NCI Surveillance, Epidemiology, and End Results database.
Yu JB; Wilson LD; Dasgupta T; Castrucci WA; Weidhaas JB
Cancer; 2008 Jul; 113(1):38-47. PubMed ID: 18442108
[TBL] [Abstract][Full Text] [Related]
16. Risk of hypothyroidism in older breast cancer patients treated with radiation.
Smith GL; Smith BD; Giordano SH; Shih YC; Woodward WA; Strom EA; Perkins GH; Tereffe W; Yu TK; Buchholz TA
Cancer; 2008 Mar; 112(6):1371-9. PubMed ID: 18213620
[TBL] [Abstract][Full Text] [Related]
17. A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.
Fong A; Shafiq J; Saunders C; Thompson AM; Tyldesley S; Olivotto IA; Barton MB; Dewar JA; Jacob S; Ng W; Speers C; Delaney GP
Breast; 2012 Aug; 21(4):570-7. PubMed ID: 22425535
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information.
Punglia RS; Weeks JC; Neville BA; Earle CC
J Clin Oncol; 2006 Jul; 24(21):3474-82. PubMed ID: 16849764
[TBL] [Abstract][Full Text] [Related]
19. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
20. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in ontario.
Mackillop WJ; Kong W; Brundage M; Hanna TP; Zhang-Salomons J; McLaughlin PY; Tyldesley S
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1099-107. PubMed ID: 25832700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]